A phase I pharmacokinetic study of ursolic acid nanoliposomes in healthy volunteers and patients with advanced solid tumors

Zhongling Zhu1 Department of Clinical Pharmacology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People’s Republic of China;4 Key Laboratory of Cancer Prevention and Therapy, Tianjin, People’s Republic of China

Zhengzi Qian2 Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People’s Republic of China;4 Key Laboratory of Cancer Prevention and Therapy, Tianjin, People’s Republic of China

Zhao Yan1 Department of Clinical Pharmacology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People’s Republic of China;4 Key Laboratory of Cancer Prevention and Therapy, Tianjin, People’s Republic of ChinaCorrespondence[email protected] [email protected]

Cuicui Zhao2 Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People’s Republic of China;4 Key Laboratory of Cancer Prevention and Therapy, Tianjin, People’s Republic of China

Huaqing Wang2 Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People’s Republic of China;4 Key Laboratory of Cancer Prevention and Therapy, Tianjin, People’s Republic of ChinaCorrespondence[email protected] [email protected]

Guoguang Ying3 Laboratory of Tumor Cell Biology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People’s Republic of China;4 Key Laboratory of Cancer Prevention and Therapy, Tianjin, People’s Republic of China

Pages 129-136 | Published online: 04 Jan 2013

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

LiuJPharmacology of oleanolic acid and ursolic acidJ Ethnopharmacol199549257688847885
PubMed Web of Science ®Google Scholar
SultanaNClinically useful anticancer, antitumor, and antiwrinkle agent, ursolic acid and related derivatives as medicinally important natural productJ Enzyme Inhib Med Chem201126561664221417964
PubMed Web of Science ®Google Scholar
KimDKBaekJHKangCMApoptotic activity of ursolic acid may correlate with the inhibition of initiation of DNA replicationInt J Cancer200087562963610925354
PubMed Web of Science ®Google Scholar
BaekJHLeeYSKangCMIntracellular Ca2+ release mediates ursolic acid-induced apoptosis in human leukemic HL-60 cellsInt J Cancer19977357257289398053
PubMed Web of Science ®Google Scholar
ChoiYHBaekJHYooMAInduction of apoptosis by ursolic acid through activation of caspases and down-regulation of c-IAPs in human prostate epithelial cellsInt J Oncol200017356557110938399
PubMed Web of Science ®Google Scholar
HarmandPODuvalRDelageCUrsolic acid induces apoptosis through mitochondrial intrinsic pathway and caspase-3 activation in M4Beu melanoma cellsInt J Cancer2005114111115523687
PubMed Web of Science ®Google Scholar
XavierCPRLimaCFPedroDFNUrsolic acid induces cell death and modulates autophagy through JNK pathway in apoptosis-resistant colorectal cancer cellsJ Nutr Biochem7262012 [Epub ahead of print.]
Web of Science ®Google Scholar
ZhangYKongCZengYUrsolic acid induces PC-3 cell apoptosis via activation of JNK and inhibition of Akt pathways in vitroMol Carcinog201049437438520146252
PubMed Web of Science ®Google Scholar
KassiESourlingasTGSpiliotakiMUrsolic acid triggers apoptosis and Bcl-2 downregulation in MCF-7 breast cancer cellsCancer Invest200927772373319440893
PubMed Web of Science ®Google Scholar
SubbaramaiahKMichaluartPSpornMBUrsolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cellsCancer Res20006092399240410811116
PubMed Web of Science ®Google Scholar
SuhNHondaTFinlayHJNovel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophagesCancer Res19985847177239485026
PubMed Web of Science ®Google Scholar
ChaHJParkMTChungHYUrsolic acid-induced down-regulation of MMP-9 gene is mediated through the nuclear translocation of glucocorticoid receptor in HT1080 human fibrosarcoma cellsOncogene19981667717789488041
PubMed Web of Science ®Google Scholar
HollosyFMeszarosGBokonyiGCytostatic, cytotoxic and protein tyrosine kinase inhibitory activity of ursolic acid in A431 human tumor cellsAnticancer Res2000206B4563457011205305
PubMed Web of Science ®Google Scholar
WuBWangXChiZ-FUrsolic acid-induced apoptosis in K562 cells involving upregulation of PTEN gene expression and inactivation of the PI3K/Akt pathwayArch Pharm Res201235354354822477202
PubMed Web of Science ®Google Scholar
PathakAKBhutaniMNairASUrsolic acid inhibits STAT3 activation pathway leading to suppression of proliferation and chemosensitization of human multiple myeloma cellsMol Cancer Res20075994395517855663
PubMed Web of Science ®Google Scholar
ZhengQ-YJinF-SYaoCUrsolic acid-induced AMP-activated protein kinase (AMPK) activation contributes to growth inhibition and apoptosis in human bladder cancer T24 cellsBiochem Biophys Res Commun2012419474174722387548
PubMed Web of Science ®Google Scholar
ShishodiaSMajumdarSBanerjeeSUrsolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1Cancer Res200363154375438312907607
PubMed Web of Science ®Google Scholar
KanjoormanaMKuttanGAntiangiogenic activity of ursolic acidIntegr Cancer Ther20109222423520462855
PubMed Web of Science ®Google Scholar
NovotnyLVachalkovaABiggsDUrsolic acid: an anti-tumorigenic and chemopreventive activityMinireview Neoplasma2001484241246
Web of Science ®Google Scholar
OvesnaZVachalkovaAHorvathovaKPentacyclic triterpenoic acids: new chemoprotective compoundsMinireview Neoplasma2004515327333
PubMed Web of Science ®Google Scholar
LiuJOleanolic acid and ursolic acid: research perspectivesJ Ethnopharmacol20051001–2929415994040
PubMed Web of Science ®Google Scholar
LiaoQYangWJiaYLC-MS determination and pharmacokinetic studies of ursolic acid in rat plasma after administration of the traditional chinese medicinal preparation Lu-Ying extractYakugaku Zasshi2005125650951515930819
PubMed Web of Science ®Google Scholar
ChenQLuoSZhangYDevelopment of a liquid chromatography–mass spectrometry method for the determination of ursolic acid in rat plasma and tissue: Application to the pharmacokinetic and tissue distribution studyAnal Bioanal Chem201139982877288421249342
PubMed Web of Science ®Google Scholar
Merisko-LiversidgeELiversidgeGGCooperERNanosizing: a formulation approach for poorly-water-soluble compoundsEur J Pharm Sci200318211312012594003
PubMed Web of Science ®Google Scholar
ZhaoCCQianZZWangHQA phase I clinical trial of ursolic acid nanoliposome for evaluating its single-dose to lerance and safetyChinese Journal of New Drugs2011202148151
Google Scholar
XiaYWeiGSiDQuantitation of ursolic acid in human plasma by ultra performance liquid chromatography tandem mass spectrometry and its pharmacokinetic studyJ Chromatogr B Analyt Technol Biomed Life Sci20118792219224
PubMed Web of Science ®Google Scholar
HsuYLKuoPLLinCCProliferative inhibition, cell-cycle dysregulation, and induction of apoptosis by ursolic acid in human non-small cell lung cancer A549 cellsLife Sci200475192303231615350828
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

A phase I pharmacokinetic study of ursolic acid nanoliposomes in healthy volunteers and patients with advanced solid tumors

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A phase I pharmacokinetic study of ursolic acid nanoliposomes in healthy volunteers and patients with advanced solid tumors

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date